The survival time for patients with bowel cancer who develop lung metastases varies significantly for each individual. For isolated lung metastases, partial removal of lung tissue is an option. After surgery, systemic intravenous chemotherapy is also required, as well as radical resection of bowel cancer, and many patients can survive for 1-2 years or even longer. In case of multiple lung metastases, the survival time is not long, but it can be controlled by adjuvant medical treatments, including systemic intravenous chemotherapy with targeted therapy and bioimmunotherapy. For lung tissue lesions, radiofrequency ablation can also be chosen to reduce the tumor load and, to a certain extent, extend the survival time of patients. Patients with bowel cancer are prone to hematogenous metastasis, and the common metastases are liver and lung tissue, and can also be metastasized to the skull and brain. Early diagnosis of bowel cancer should be actively treated by surgery, and the survival time is very satisfactory, and regular colonoscopy is also needed.